Cognitive and socio-emotional deficits in platelet-derived growth factor receptor-β gene knockout mice

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Nguyen, Phuong Thi Hong ^a   Nakamura, Tomoya ^a   Hori, Etsuro ^a   Urakawa, Susumu ^a   Uwano, Teruko ^a   Zhao, Juanjuan ^a   Li, Ruixi ^a   Bac, Nguyen Duy ^a   Hamashima, Takeru ^a   Ishii, Yoko ^a   Matsushima, Takako ^a   Ono, Taketoshi ^a   Sasahara, Masakiyo ^a   Nishijo, Hisao ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; PARVALBUMIN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; COGNITIVE DEFECT; CONDITIONING; CONTROLLED STUDY; DNA FLANKING REGION; EMOTIONAL DISORDER; EVENT RELATED POTENTIAL; EVOKED RESPONSE; FORCED SWIMMING TEST; FRAMESHIFT MUTATION; GENE INACTIVATION; GENOTYPE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEUROANATOMY; NEUROPHYSIOLOGY; NOCICEPTION; NONHUMAN; OSCILLATION; PREPULSE INHIBITION; PROTEIN EXPRESSION; SCHIZOPHRENIA; SENSORY GATING; SOCIAL DISABILITY; SOCIAL INTERACTION; SPATIAL MEMORY; STARTLE REFLEX; TRANSGENE; ACOUSTICS; ANIMAL; BRAIN; EMOTION; FEAR; FREEZING; GENETICS; METABOLISM; MOTOR ACTIVITY; MOUSE MUTANT; NERVE CELL; NOCICEPTIVE RECEPTOR; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SOCIAL BEHAVIOR; SWIMMING; TIME;

MUS;

ACOUSTICS; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; COGNITION DISORDERS; CONDITIONING (PSYCHOLOGY); EMOTIONS; EVOKED POTENTIALS; FEAR; FREEZING; GENE KNOCKOUT TECHNIQUES; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; NEURONS; NOCICEPTORS; PARVALBUMINS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; SOCIAL BEHAVIOR; STARTLE REACTION; SWIMMING; TIME FACTORS;

EID: 79952790868     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018004     Document Type: Article

References (81)

1. Fredriksson L, Li H, Eriksson U, (2004) The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev 15: 197-204.
2. Heldin CH, Ostman A, Ronnstrand L, (1998) Signal transduction via platele-derived growth factor receptors. Biochimica et biophysica Acta 1378: 79-113.
3. Smits A, Kato M, Westermark B, Nister M, Heldin CF, et al. (1991) Neurotrophic activity of platelet-derived growth factor (PDGF): rat neuronal cells possess functional PDGF-β type receptors and respond to PDGF. Proc Natl Acad Sci USA 88: 8159-8163.
4. Sasahara M, Amano S, Sato H, Yang JG, Hayase Y, et al. (1998) Normal developing rat brain expresses a platelet-derived growth factor B chain (c-sis) mRN A truncated at the 5' end. Oncogene 16: 1571-1578.
5. Sasahara M, Fries JWU, Raines EW, Gown AM, Westrum LE, et al. (1991) PDGF-B chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model. Cell 64: 217-227.
6. Sasahara A, Kott JL, Sasahara M, Raines EW, Ross R, et al. (1992) Platelet-derived growth factor B-chain-like immunoreactivity in the developing and adult rat brain. BrainRes Dev BrainRes 68: 41-53.
7. Heldin CH, Westermark B, (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79 (4): 1283-1316.
8. Andrae J, Gallini R, Betsholtz C, (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22: 1276-1312.
9. International Human Genome Sequencing Consortium (2004) Finishing the euchrmatic sequence in human genome. Nature 431 (7011): 931-945.
10. Silverman JM, Greenberg DA, Altstiel LD, Siever LJ, Mohs RC, et al. (1996) Evidence of a locus for schizophrenia and related disorders on the short arm of chromosome 5 in a large pedigree. Am J Med Genet 67 (2): 162-171.
11. Straub RE, MacLean CJ, O'Neill FA, Walsh D, Kendler KS, (1997) Support for a possible schizophrenia vulnerability locus in region 5q22-31 in Irish families. Mol Psychiatry 2 (2): 148-155.
12. Shaw SH, Kelly M, Smith AB, Shields G, Hopkins PJ, et al. (1998) A genome-wide search for schizophrenia susceptibility genes. Am J Med Genet 81 (5): 364-376.
13. Gurling HM, Kalsi G, Brynjolfson J, Sigmundsson T, Sherrington R, et al. (2001) Genome wide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am J Hum Genet 68 (3): 661-673.
14. DeLisi LE, Mesen A, Rodriguez C, Bertheau A, LaPrade B, et al. (2002) Genome-wide scan for linkage to schizophrenia in a Spanish-origin cohort from CostaRica. Am J Med Genet 114 (5): 497-508.
15. Devlin B, Bacanu SA, Roeder K, Reimherr F, Wender P, et al. (2002) Genome-wide multi point linkage analyses of multiplex schizophrenia pedigrees from the oceanic nation of Palau. Mol Psychiatry 7 (7): 689-694.
16. Sklar P, Pato MT, Kirby A, Petryshen TL, Medeiros H, et al. (2004) Genome-wide scan in Portuguese Island families identifies 5q31-5q35 as a susceptibility locus for schizophrenia and psychosis. Mol Psychiatry 9 (2): 213-218.
17. Herzberg I, Jasinska A, Garcia J, Jawaheer D, Service S, et al. (2006) Convergent linkage evidence from two Latin-American population isolates supports the presence of a susceptibility locus for bipolar disorder in 5q31-34. Hum Mol Genet 15 (21): 3146-3153.
18. Sherrington R, Brynjolfsson J, Petursson H, Potter M, Dedleston K, et al. (1988) Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature 336 (6195): 164-167.
19. Kotecha SA, Oak JN, Jackson MF, Perez Y, Orser BA, et al. (2002) A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission. Neuron 35: 1111-1122.
20. Smits A, Ballagi AE, Funa K, (1993) PDGF-BB exerts trophic activity on cultured GABA interneurons from the newborn rat cerebellum. Eur J Neurosci 5: 986-994.
21. Othberg A, Odin P, Ballagi A, Ahgren A, Funa K, et al. (1995) Specific effects of platelet derived growth factor (PDGF) on fetal rat and human dopaminergic neurons in vitro. Exp Brain Res 105 (1): 111-122.
22. Valenzuela CF, Xiong Z, MacDonald JF, Weiner JL, Frazier CJ, et al. (1996) Platelet-derived growth factor induces a long-term inhibition of N-methyl-D-aspartate receptor function. J Biol Chem 271 (27): 16151-16159.
23. Lei S, Lu WY, Xiong ZG, Orser BA, Valenzuela CF, et al. (1999) Platelet-derived growth factor receptor induced feed-forward inhibition of excitatory transmission between hippocampal pyramidal neurons. J Biol Chem 274: 30617-30623.
24. Kim HJ, Kim MH, Choe BK, Kim JW, Park JK, et al. (2008) Genetic association between 5'-upstream single-nucleotide polymorphisms of PDGFRB and schizophrenia in a Korean population. Schizophr Res 103: 201-208.
25. Kajizuka M, Miyachi T, Matsuzaki H, Iwata K, Shinmura C, et al. (2010) Serum levels of platelet-derived growth factor BB homodimers are increased in male children with autism. Prog Neuropsychopharmacol Biol Psychiatry 34: 154-158.
26. Ishii Y, Oya T, Zheng L, Gao Z, Kawaguchi M, et al. (2006) Mouse brains deficient in neuronal PDGF receptor-β develop normally but are vulnerable to injury. J Neurochemistry 98: 588-600.
27. Lewis DA, Hashimoto T, Volk DW, (2005) Cortical inhibitory neurons and schizophrenia. Nature Rev 6: 312-324.
28. Lewis DA, Gonzalez-Burgos G, (2006) Pathophysiologically based treatment interventions in schizophrenia. Nature Med 12: 1016-1022.
29. Gogolla N, Leblanc JJ, Quast KB, Südhof T, Fagiolini M, et al. (2009) Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J Neurodev Disord 1: 172-181.
30. Roach BJ, Mathalon HD, (2008) Event-related eeg time-frequency analysis: an overview of measures and an analysis of early gamma band phase locking in schizophrenia. Schizophr Bull 34: 907-926.
31. Hall M-H, Taylor G, Sham P, Schulze K, Rijsdijk F, et al. (2009) The early auditory gamma-band response is heritable and a putative endophenotype of schizophrenia. Schizophr Bull pp. 10.1093/schbul/sbp134 (online).
32. Leicht G, Kirsch V, Giegling I, Karch S, Hantschk I, et al. (2010) Reduced early auditory evoked gamma-band response in patients with schizophrenia. Biol Psychiatry 67 (3): 224-231.
33. Gao Z, Sasaoka T, Fujimori T, Oya T, Ishii Y, et al. (2005) Deletion of the PDGFR-beta gene affects key fibroblast functions important for wound healing. J BiolChem 280: 9375-9389.
34. Ishii Y, Matsumoto Y, Watanabe R, Elmi M, Fujimori T, et al. (2008) Characterization of neuroprogenitor cells expressing the PDGF beta-receptor within the subventricular zone of postnatal mice. Mol Cell Neurosci 37: 507-518.
35. Bannon AW, Malmberg AB, (2007) Models of nociception: hot-plate, tail-flick, and formalin tests in rodents. Curr Protoc Neurosci. Chapter 8: Unit 8.9.
36. Kurokawa M, Fujimura K, Sakurai-Yamashita Y, (2003) A new-generation apparatus for studying memory-related performance in mice. Cell Mol Neurobiol 23 (2): 121-129.
37. Hof PR, Young WG, Bloom FE, Belichenko PV, Celio MR, (2000) Comparative Cytoarchitectonic Atlas of C57BL/6 and 129/Sv Mouse. Amsterdam Elsevier Science.
38. Phillips JM, Ehrlichman RS, Siegel SJ, (2007) Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma. Neuroscience 144 (4): 1314-1323.
39. Neeta PN, Anitha KP, Ramona MR, Kelly LG, Galina PD, et al. (2005) Neural cell adhension molecule-secreting transgenic mice display abnormalities in GABAergic interneurons and alteration in behavior. J Neuroscience 25 (18): 4659-4671.
40. Kwon CH, Luikart BW, Powell CM, Zhou J, Matheny SA, et al. (2006) Pten regulates neuronal arborization and social interaction in mice. Neuron 50: 377-388.
41. Elisabeth B, Jia BW, (2009) Anti-depressant and anxiolytic like behaviors in PKCI/HINTI knockout mice associated with elevated plasma corticosterone level. Neuroscience 10: 132-146.
42. Nabeshima T, Mouri A, Murai R, Noda Y, (2006) Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine. Ann N Y Acad Sci 1086: 160-168.
43. Moy SS, Nadler JJ, Magnuson TR, Crawley JN, (2006) Mouse models of autism spectrum disorders: the challenge for behavioral genetics. Am J Med Genet C Semin Med Genet 142C: 40-51.
44. Stahl SM, Buckley PF, (2007) Negative symptoms of schizophrenia: a problem that will not go away. Acta Psychiatr Scand 115: 4-11.
45. Tandona R, Nasrallahb HA, Keshavanc MS, (2009) Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr Res 110: 1-23.
46. O'Tuathaigh CPM, Kirby BP, Moran PM, Waddington JL, (2010) Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia. Schizophrenia Bulletin 6: 271-288.
47. Kalueff AV, Nutt DJ, (2007) Role of GABA in anxiety and depression. Depress Anxiety 24: 495-517.
48. Pollack MH, Jensen JE, Simon NM, Kaufman RE, Renshaw PF, (2008) High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam. Prog Neuropsychopharmacol Biol Psychiatry 32: 739-743.
49. Schmajuk NA, Larrauri JA, (2005) Neural network model of prepulse inhibition. Behavioral Neuroscience 119: 1546-1562.
50. Fendt M, Schwienbacher I, Koch M, (2000) Amygdaloid N-methyl- D-aspartate and gamma-aminobutyric acid(A) receptors regulate sensorimotor gating in a dopamine-dependent way in rats. Neuroscience 98: 55-60.
51. Hauser J, Rudolph U, Keist R, Möhler H, Feldon J, et al. (2005) Hippocampal α5 subunit-containing GABAA receptors modulate the expression of prepulse inhibition. Molecular Psychiatry 10: 201-207.
52. Fejgin K, Pålsson E, Wass C, Finnerty N, Lowry J, et al. (2009) Prefrontal GABA(B) receptor activation attenuates phencyclidine-induced impairments of prepulse inhibition: involvement of nitric oxide. Neuropsychopharmacology 34: 1673-1684.
53. Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AD, et al. (2007) Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr Bull 33: 69-94.
54. Swerdlow NR, Geyer MA, (1998) Using ananimal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 24: 285-301.
55. Geyer MA, McIlwain KL, PaylorR, (2002) Mouse genetic models for pre-pulse inhibition: an early review. Mol Psychiatry 7: 1039-1053.
56. McAlonan GM, Daly E, Kumari V, Critchley HD, van Amelsvoort T, et al. (2002) Brain anatomy and sensorimotor gating in Asperger's syndrome. Brain 125 (Pt 7): 1594-1606.
57. Perry W, Minassian A, Lopez B, Maron L, Lincoln A, (2007) Sensorimotor gating deficits in adults with autism. Biological Psychiatry 61: 482-486.
58. Schumann CM, Hamstra J, Goodlin-Jones BL, Lotspeich LJ, Kwon H, et al. (2004) The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages. J Neurosci 24: 6392-6401.
59. Suzuki M, Zhou SY, Takahashi T, Hagino H, Kawasaki Y, et al. (2005) Differential contributions of prefrontal and temporolimbic pathology to mechanisms of psychosis. Brain 2005 Sep; 128 (Pt 9): 2109-2122.
60. Hanlon FM, Weisend MP, Hamilton DA, Jones AP, Thoma RJ, et al. (2006) Impairment on the hippocampal-dependent virtual Morris water task in schizophrenia. Schizophrenia Research 87: 67-80.
61. Andersen JD, Pouzet B, (2004) Spatial memory deficits induced by perinatal treatment of rats with PCP and reversal effect of D-serine. Neuropsychopharmacology 29: 1080-1090.
62. Hofer E, Doby D, Anderer P, Dantendorfer K, (2001) Impaired conditional discrimination learning in schizophrenia. Schizophrenia Res 51: 127-136.
63. Gaigg SB, Dermot M, Bowler DM, (2007) Differential fear conditioning in Asperger's syndrome: Implications for an amygdala theory of autism. Neuropsychologia 45: 2125-2134.
64. Satomoto M, Satoh Y, Terui K, Miyao H, Takishima K, et al. (2009) Neonatal exposure to sevoflurane induces abnormal social behaviors and deficits in fear conditioning in mice. Anesthesiology 110: 628-637.
65. Vukmir V, Narong S, Evelyne G, David G, (2001) PDGF-Receptor expression in the dorsocaudal brainstem parallels hypoxic ventilatory depression in the developing rat. Pediatric Research 50 (2): 236-241.
66. Peng F, Yao H, Bai X, Zhu X, Reiner BC, et al. (2010) Platelet-derived growth factor-mediated induction of the synaptic plasticity gene Arc/Arg3.1. Journal of Biological Chemistry 285: 21615-21624.
67. Shioda N, Moriguchi S, Yamamoto Y, Matsushima T, Sasahara M, et al. (2009) Changes in hippocampal spine morphology and synaptic plasticity induced by conditional loss of PDGFR-β are associated with memory impairment in mutant mice. Neurosci Res 65 (Suppl 1): S67.
68. Ploski JE, Pierre VJ, Smucny J, Park K, MMonsey MS, et al. (2008) The activity-regulated cytoskeletal-associated protein (Arc/Arg3.1) is required for memory consolidation of pavlovian fear conditioning in the lateral amygdala. J Neurosci 28: 12383-12395.
69. Cheng B, Mattson MP, (1995) PDGFs protect hippocampal neurons against energy deprivation and oxidative injury: evidence for induction of antioxidant pathways. J Neurosci 15: 7095-7104.
70. Zheng L, Ishii Y, Tokunaga A, Hamashima T, Shen J, et al. (2010) Neuroprotective effects of PDGF against oxidative stress and the signaling pathway involved. J Neurosci Res 88: 1273-1284.
71. Behrens MM, Sejnowski TJ, (2009) Does schizophrenia arise from oxidative dysregulation of parvalbumininterneurons in the developing cortex? Neuropharmacology 57: 193-200.
72. Kawaguchi Y, Kubota Y, (1998) Neurochemical features and synaptic connections of large physiologically-identified GABAergic cells in the rat frontal cortex. Neuroscience 85: 677-701.
73. Toledo-Rodriguez M, Blumenfeld B, Wu C, Luo J, Attali B, et al. (2004) Correlation maps allow neuronal electrical properties to be predicted from single-cell gene expression profiles in rat neocortex. Cereb Cortex 14: 1310-1327.
74. Cardin JA, Carlén M, Meletis K, Knoblich U, Zhang F, et al. (2009) Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature 459: 663-668.
75. Sohal VS, Zhang F, Yizhar O, Deisseroth K, (2009) Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 459: 698-702.
76. Lee K-H, Williamsa LM, Breakspear M, Gordon E, (2003) Synchronous Gamma activity: a review and contribution to an integrative neuroscience model of schizophrenia. Brain Res Rev 41: 57-78.
77. Orekhova EV, Stroganova TA, Nygren G, Tsetlin MM, Posikera IN, et al. (2007) Excess of high frequency electroencephalogram oscillations in boys with autism. Biol Psychiatry 62: 1022-1029.
78. Rojas DC, Maharajh K, Teale P, Rogers SJ, (2008) Reduced neural synchronization of gamma-band MEG oscillations in first-degree relatives of children with autism. BMC Psychiatry 8: 66.
79. Lodge DJ, Behrens MM, Grace AA, (2009) A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J Neurosci 29: 2344-2354.
80. Burbach JP, van der Zwaag B, (2009) Contact in the genetics of autism and schizophrenia. Trends Neurosci 32 (2): 69-72.
81. Cheung C, Yu K, Fung G, Leung M, Wong C, et al. (2010) Autistic disorders and schizophrenia: related or remote? An anatomical likelihood estimation. PLoS ONE 5 (8): e12233.